[ Price : $8.95]
Baxter recalls its AK 98 dialysis machines based on recent recalls by other manufacturers related to the potential risk of exposur...[ Price : $8.95]
FDA publishes a guidance to help sponsors planning to use circulating tumor DNA as a biomarker in some cancer trials.[ Price : $8.95]
FDA releases the form FDA-483 with four observations from a 2023 inspection at the Monza, Italy-based Patheon Italia sterile drug ...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Recommended Follow-up Testing for an Ames-Positive Drug (Ac...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Assessment of Ovarian Toxicity in Premenopausal Adults Duri...[ Price : $8.95]
Federal Register notice: FDA renews its Oncologic Drugs Advisory Committee for an additional two years.[ Price : $8.95]
FDA identifies eight broad areas for the GDUFA FY 2025 science and research priorities.[ Price : $8.95]
PTC Therapeutics says its utreloxastat failed to meet the primary endpoint in a Phase 2 ALS study and development will not continu...